[1]
2025. Inflammatory biomarkers in the prediction of residual cardiovascular risk in patients with metabolic syndrome: An integrative literature review. Research, Society and Development. 14, 10 (Oct. 2025), e17141049582. DOI:https://doi.org/10.33448/rsd-v14i10.49582.